Literature DB >> 16082113

Effects of various selective phosphodiesterase inhibitors on carbachol-induced contraction and cyclic nucleotide contents in the guinea pig gall bladder.

Takeharu Kaneda1, Akitoshi Watanabe, Kazumasa Shimizu, Norimoto Urakawa, Shinjiro Nakajyo.   

Abstract

The effects of various selective phosphodiesterase (PDE) inhibitors on muscle contractility and cyclic nucleotide contents in the guinea pig gall bladder were investigated. Various selective PDE inhibitors, vinpocetine (type 1), erythro-9-(2-hydroxy-3-nonyl)adenine (EHNA, type 2), milrinone (type 3), Ro20-1724 (type 4), and zaprinast (type 5), inhibited CCh-induced contractions in a concentration-dependent manner. The rank order of potency for the gall bladder was Ro20-1724 > vinpocetine > EHNA > milrinone > zaprinast, which was different from that of the trachea, taenia coli, and aorta. In the presence of CCh (0.3 muM), vinpocetine, milrinone, and Ro20-1724 each increased cAMP content, but not cGMP. By contrast, zaprinast increased cGMP content, but not cAMP, and EHNA increased both cAMP and cGMP contents. These results suggest that vinpocetine-, milrinone-, and Ro20-1724-induced relaxation was correlated with cAMP, zaprinast-induced relaxation was correlated with cGMP, and that EHNA-induced relaxation was correlated with cAMP and cGMP in the guinea pig gall bladder. In conclusion, the effect of PDE inhibitors in the guinea pig gall bladder was different from those in smooth muscles, such as the trachea, taenia coli, and aorta.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16082113     DOI: 10.1292/jvms.67.659

Source DB:  PubMed          Journal:  J Vet Med Sci        ISSN: 0916-7250            Impact factor:   1.267


  4 in total

1.  PDE4 and PDE5 regulate cyclic nucleotide contents and relaxing effects on carbachol-induced contraction in the bovine abomasum.

Authors:  Takeharu Kaneda; Yuuki Kido; Tsuyoshi Tajima; Norimoto Urakawa; Kazumasa Shimizu
Journal:  J Vet Med Sci       Date:  2014-10-15       Impact factor: 1.267

2.  Effect of Roflumilast in airways disorders via dual inhibition of phosphodiesterase and Ca2+-channel.

Authors:  Faisal Imam; Najeeb Ur Rehman; Mohd Nazam Ansari; Wajhul Qamar; Muhammad Afzal; Khalid Saad Alharbi
Journal:  Saudi Pharm J       Date:  2020-04-25       Impact factor: 4.330

3.  In Silico, Ex Vivo and In Vivo Studies of Roflumilast as a Potential Antidiarrheal and Antispasmodic agent: Inhibition of the PDE-4 Enzyme and Voltage-gated Ca++ ion Channels.

Authors:  Najeeb Ur Rehman; Mohd Nazam Ansari; Abdul Samad
Journal:  Molecules       Date:  2020-02-24       Impact factor: 4.411

4.  Imidazole-induced contractions in bovine tracheal smooth muscle are not dependent on the cAMP pathway.

Authors:  Takeharu Kaneda; Hidenori Kanda; Tsuyoshi Tajima; Norimoto Urakawa; Kazumasa Shimizu
Journal:  J Vet Med Sci       Date:  2017-12-18       Impact factor: 1.267

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.